James Paul Kastenmayer serves as General Counsel at ArriVent BioPharma, Inc., where they oversee executive responsibilities. Since joining the company, James Paul Kastenmayer has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 2, 2026 involved receiving (via award) 130,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | AVBP | $0 | Award | 130,000 | $N/A | Discretionary |
James Paul Kastenmayer currently holds 130,000 shares of ArriVent BioPharma, Inc. (AVBP), valued at approximately $0. This represents their equity stake as General Counsel.
Based on SEC Form 4 filings, James Paul Kastenmayer has been a net neutral trader of AVBP stock. They have purchased $0 and sold $0 worth of shares.
James Paul Kastenmayer's most recent insider trade was on Feb 2, 2026, when they sold 130,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted